Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cytotoxic agents that preferentially target leukemia inhibitory factor (LIF) for the treatment of malignancies and as new contraceptive agents

Cytotoxic agents that preferentially target leukemia inhibitory factor (LIF) for the treatment of malignancies and as new contraceptive agents

US Patent 10053485 · Granted Aug 21, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cytotoxic agents that preferentially target leukemia inhibitory factor (LIF) for2020
Cytotoxic agents that preferentially target leukemia inhibitory factor (LIF) for2020
Cytotoxic agents that preferentially target leukemia inhibitory factor (LIF) for2020
Longer-acting progestin prodrug contraceptives2020
Longer-acting progestin prodrug contraceptives2020
Pro-drug forming compounds2019
Pro-drug forming compounds2019
Pro-drug forming compounds2019
Combination of estrogens plus antiprogestins with significant partial agonistic 2017
Combination of estrogens plus antiprogestins with significant partial agonistic 2017
Combination of estrogens plus antiprogestins with significant partial agonistic 2017
Pro-drug forming compounds2017